# Zentalis Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/zentalis-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:39.768585+00:00 | | Last reviewed | 2026-10-17T04:46:39.768585+00:00 | ## Identity - Legal name: Zentalis Pharmaceuticals, Inc. - Display name: Zentalis Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T09:32:27.925885+00:00 | | Completeness | 0.409 | | Record Quality | 0.838 | | Directors | 7 | | Committees | 5 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - David Johnson: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:5 - Enoch Kariuki, Pharm.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:6 - Jan Skvarka, Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:7 - Julie Eastland: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:8 - Karan Takhar: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:9 - Luke Walker, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member). claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:10 - Scott Myers: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:11 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Luke Walker, M.D. (member, current); Scott Myers (member, current). committee_id=alpha:committee:zentalis-pharmaceuticals-inc:audit - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Scott Myers (member, current). committee_id=alpha:committee:zentalis-pharmaceuticals-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: David Johnson (member, current); Karan Takhar (member, current); Scott Myers (member, current). committee_id=alpha:committee:zentalis-pharmaceuticals-inc:compensation - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Karan Takhar (member, current). committee_id=alpha:committee:zentalis-pharmaceuticals-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Karan Takhar. Members: Karan Takhar (chair, current); Scott Myers (member, current). committee_id=alpha:committee:zentalis-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Ingmar Bruns, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:12 - James Bucher: Chief Legal Officer and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:13 - Julie Eastland: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:14 ## Governance events - EXECUTIVE_APPOINTED: Ingmar Bruns, M.D. executive of Zentalis Pharmaceuticals, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:frrvldx3vz2v - GC_CHANGED: James Bucher executive of Zentalis Pharmaceuticals, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1t00bsa1ab021q - CEO_CHANGED: Julie Eastland executive of Zentalis Pharmaceuticals, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1gpatlx11eu7mt - DIRECTOR_APPOINTED: Julie Eastland seat on Zentalis Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1udrm6t49080h - DIRECTOR_APPOINTED: Luke Walker, M.D. seat on Zentalis Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:52ckloxxlins - DIRECTOR_APPOINTED: Scott Myers seat on Zentalis Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:hx5rkh1xgnqoh - COMMITTEE_MEMBER_ADDED: Luke Walker, M.D. member of Audit, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1iuror71usx5k5 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of Zentalis Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1ut1ust1saoxh5 - COMMITTEE_MEMBER_ADDED: Scott Myers member of Audit; Compensation; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:vbcxzz18h31ch - DIRECTOR_APPOINTED: Jan Skvarka, Ph.D. seat on Zentalis Pharmaceuticals, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:wgm8lydymo3w - DIRECTOR_APPOINTED: Enoch Kariuki, Pharm.D. seat on Zentalis Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1d01rkq8jio2q - DIRECTOR_APPOINTED: David Johnson seat on Zentalis Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:gw4lakxhi5o0 - COMMITTEE_MEMBER_ADDED: David Johnson member of Compensation, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:m3l8yb1g40cjp - DIRECTOR_APPOINTED: Karan Takhar seat on Zentalis Pharmaceuticals, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:1drveach7jzqw - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Zentalis Pharmaceuticals, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:mnxuoozfmzi0 - COMMITTEE_MEMBER_ADDED: Karan Takhar member of Compensation; Nominating and Governance · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:39.768585+00:00. event_id=alpha:event:transition:duowr2iazfb0 ## Scoped resources - `alpha://company/zentalis-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record - `alpha://company/zentalis-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/zentalis-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/zentalis-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=board - `alpha://company/zentalis-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/zentalis-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/zentalis-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/zentalis-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/zentalis-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/zentalis-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/zentalis-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/zentalis-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/zentalis-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/zentalis-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/zentalis-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/zentalis-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/zentalis-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/zentalis-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/zentalis-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/zentalis-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=events - `alpha://company/zentalis-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/zentalis-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/zentalis-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:luke-walker-md","name":"Luke Walker, M.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:scott-myers","name":"Scott Myers"},"source_id":"board_seats"}` - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:david-johnson","name":"David Johnson"},"source_id":"board_seats"}` - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:karan-takhar","name":"Karan Takhar"},"source_id":"board_seats"}` - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:scott-myers","name":"Scott Myers"},"source_id":"board_seats"}` - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:karan-takhar","name":"Karan Takhar"},"source_id":"board_seats"}` - Claim alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:scott-myers","name":"Scott Myers"},"source_id":"board_seats"}` ## Leadership - David Johnson: Director, Compensation. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Enoch Kariuki, Pharm.D.: Director. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Jan Skvarka, Ph.D.: Director. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Julie Eastland: Director. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Karan Takhar: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Luke Walker, M.D.: Director, Audit. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Scott Myers: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70. - Ingmar Bruns, M.D.: Chief Medical Officer. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:12. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cca0bae28bc2ae6996bb75bc1ccae43dab9a3778fc29eac3e6b4119646d5ea32. - James Bucher: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:13. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d3cfa1a29ad9e7b91c68ba4032827427ecee4e91dffb19f91d631614010d5eb. - Julie Eastland: President, Chief Executive Officer and Director. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:leadership_role:14. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:124308b002b03cf12b896c13380e2a13eea715f807d49085cd20da19318af81b. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Luke Walker, M.D.; Scott Myers. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Compensation: Chair not stated; Members David Johnson; Karan Takhar; Scott Myers. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Nominating and Governance: Chair Karan Takhar; Members Karan Takhar (Chair); Scott Myers. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Zentalis Pharmaceuticals, Inc.. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b3c46e684f6148cd259919c0a84be6aa80090bfdc10ff0a81e2febf4ce78c1a8. ## Entity Status - Public listing published. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b3c46e684f6148cd259919c0a84be6aa80090bfdc10ff0a81e2febf4ce78c1a8. ## Published Fact - US. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b3c46e684f6148cd259919c0a84be6aa80090bfdc10ff0a81e2febf4ce78c1a8. ## Committee Appointment - Luke Walker, M.D.: member, Audit. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Scott Myers: member, Audit. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - David Johnson: member, Compensation. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Karan Takhar: member, Compensation. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Scott Myers: member, Compensation. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Karan Takhar: chair, Nominating and Governance. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. - Scott Myers: member, Nominating and Governance. Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94. ## Security Listing - ZNTL (NASDAQ). Claim: alpha:claim:company:fcfb61fc-8838-4ab6-a35a-42d6f8662edb:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b3c46e684f6148cd259919c0a84be6aa80090bfdc10ff0a81e2febf4ce78c1a8. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:b3c46e684f6148cd259919c0a84be6aa80090bfdc10ff0a81e2febf4ce78c1a8: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc). - alpha:projection-evidence:document:b394611f2d3134b3d46b79c034a257d5adb7acc0ef85b3e81b9c2006e3b6bd70: [Zentalis Pharmaceuticals, Inc. DEF 14A 2025-04-30](https://www.sec.gov/Archives/edgar/data/1725160/000172516025000092/zntl-20250430.htm). - alpha:projection-evidence:document:cca0bae28bc2ae6996bb75bc1ccae43dab9a3778fc29eac3e6b4119646d5ea32: [ZNTL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1725160/000172516026000027/zntl-20260429.htm). - alpha:projection-evidence:document:5d3cfa1a29ad9e7b91c68ba4032827427ecee4e91dffb19f91d631614010d5eb: [ZNTL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1725160/000172516026000027/zntl-20260429.htm). - alpha:projection-evidence:document:124308b002b03cf12b896c13380e2a13eea715f807d49085cd20da19318af81b: [ZNTL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1725160/000172516026000027/zntl-20260429.htm). - alpha:projection-evidence:4ece2d26880c76d07fd91f1c4ccf9a3d437bc5d28589286a4ef9b22028518a94: [Audit](https://www.sec.gov/Archives/edgar/data/1725160/000172516025000092/zntl-20250430.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/zentalis-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/zentalis-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/zentalis-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/zentalis-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T09:32:27.685735+00:00; recorded 2026-10-17T09:32:27.685735+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.